Nine major pharmaceutical companies have agreed to pool data on drug trials with academic institutions in an effort to improve ways of developing of new prescription medicines to treat psychiatric disorders such as schizophrenia. The collaboration, which involves Pfizer, AstraZeneca, Eli Lilly and Roche among others, will bring together data on 67 trials on 11 [...]
Continue reading...Tuesday, August 11, 2009
Using oseltamivir, marketed as Tamiflu, early in the course of the flu reduces complications and hospitalizations in children and adolescents with chronic medical conditions such as asthma, according to a new study. Using anonymous data from MarketsSan databases (Thomson Reuters, Cambridge, Massachusetts), Dr. Pedro A. Piedra from Baylor College of Medicine, Houston and colleagues studied [...]
Continue reading...
Thursday, November 11, 2010
0 Comments